At Material Flow Solutions, we supply cost effective, engineered solutions based on measurement of key material flow properties. We provide material property testing combined with 40 years of design experience to solve flow problems facing today’s producers of fine powders in the pharmaceutical industry.

With decades of experience in the powder and particle industry, we recognized the need for advancement in two very specific areas. 

  • Segregation potential measurement and prediction for REAL mixtures – not simple bimodal mixtures, but mixtures of multiple components.
  • Powder flowability measurement at product formulation time, at contact pressures low enough to correlate with REAL tablet/capsule fill systems, and in sample quantities small enough to be affordable when high-cost preliminary production quantities are all that is available.

We met the need by developing the SPECTester® segregation quantifier and the SSSpinTester® strength and density analyzer.

We use these commercially available instruments in our in-house laboratory to directly measure the powder characteristics data necessary to successfully design processes with minimal flow issues and tablets/capsules with significantly reduced off-specification product runs.

Using the SPECTester to evaluate product segregation

Material Flow Solutions, Inc.
5921 N County Rd 225
Gainesville, Florida 32609
Phone: (352) 379-8879

Go to article: Home | Data DrivenGo to article: BrooksGo to article: EditorialGo to article: ContentsGo to article: Daiichi JitsugyoGo to article: LaudaGo to article: NewsGo to article: Fisher Clinical ServicesGo to article: Fisher Clinical Services Company InsightGo to article: The pharma industry briefingGo to article: EcocoolGo to article: Roundtable: experts share their thoughts on Brexit’s impact on clinical trialsGo to article: Cryo StoreGo to article: Opening up the Chinese drug marketGo to article: DelSiTechGo to article: Boosting biosimilar uptake in the US: what needs to change.Go to article: PharmasolGo to article: TriNetX: Using real-world data to improve clinical research Go to article: SmartCAEGo to article: SmartCAE Company InsightGo to article: Unlocking cell-free protein synthesis: biotech’s next big ticketGo to article: Capsugel Company InsightGo to article: Immunising against opioids – could a vaccine solve the crisis? Go to article: AlpexGo to article: Curing hepatitis C at a fraction of the costGo to article: ILC Dover IncGo to article: Why artificial intelligence and pharmaceuticals are a perfect matchGo to article: Material Flow SolutionsGo to article: Material Flow Solutions Company InsightGo to article: Shaky foundations: the flaws in animal research reportingGo to article: Global Freight Solutions LtdGo to article: Paying the bill for innovative gene and cell therapies Go to article: CBDepotGo to article: CBDepot Company InsightGo to article: EventsGo to article: Bea TechnologiesGo to article: Next issueGo to article: Event: CPhI KoreaGo to article: Syne Qua Non Ltd